Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

Similar articles for PubMed (Select 24052166)

1.

MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.

Zhu H, Luo H, Zuo X.

Exp Mol Med. 2013 Sep 20;45:e41. doi: 10.1038/emm.2013.71. Review.

2.

The Role of PPAR Gamma in Systemic Sclerosis.

Dantas AT, Pereira MC, de Melo Rego MJ, da Rocha LF Jr, Pitta Ida R, Marques CD, Duarte AL, Pitta MG.

PPAR Res. 2015;2015:124624. doi: 10.1155/2015/124624. Epub 2015 May 6. Review.

3.

Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.

Luo Y, Wang Y, Shu Y, Lu Q, Xiao R.

Int J Biochem Cell Biol. 2015 Jun 1. pii: S1357-2725(15)00154-5. doi: 10.1016/j.biocel.2015.05.023. [Epub ahead of print] Review.

PMID:
26043891
4.

Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis.

Dimitroulas T, Daoussis D, Garyfallos A, Sfikakis PP, Kitas GD.

Curr Med Chem. 2015;22(16):1943-55.

PMID:
25850767
5.

Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders.

Kamal MA, Mushtaq G, Greig NH.

CNS Neurol Disord Drug Targets. 2015;14(4):492-501.

PMID:
25714967
6.

The role of microRNAs in equine medicine: a review.

van der Kolk JH, Pacholewska A, Gerber V.

Vet Q. 2015 Jun;35(2):88-96. doi: 10.1080/01652176.2015.1021186. Epub 2015 Mar 24.

PMID:
25695624
7.

Promising anti-fibrotic approaches for future treatment of systemic sclerosis.

H W Distler J, Distler O.

Curr Rheumatol Rev. 2010;6(4):305-8.

PMID:
25693045
8.

Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets.

Lewis A, Nijhuis A, Mehta S, Kumagai T, Feakins R, Lindsay JO, Silver A.

Inflamm Bowel Dis. 2015 May;21(5):1141-50. doi: 10.1097/MIB.0000000000000298.

PMID:
25636122
9.

MicroRNAs in the biology and diagnosis of cholangiocarcinoma.

Piontek K, Selaru FM.

Semin Liver Dis. 2015 Feb;35(1):55-62. doi: 10.1055/s-0034-1397349. Epub 2015 Jan 29.

PMID:
25632935
10.

Abnormalities of selenium but not of copper homeostasis may drive tissue fibrosis in patients with systemic sclerosis.

Hughes M, Cooper GJ, Wilkinson J, New P, Guy JM, Herrick AL.

Rheumatology (Oxford). 2015 Apr;54(4):747-8. doi: 10.1093/rheumatology/keu470. Epub 2015 Jan 18. No abstract available.

PMID:
25602061
11.

New potential biomarkers for disease activity and fibrosis in systemic sclerosis.

Vadasz Z, Rimar D.

Isr Med Assoc J. 2014 Oct;16(10):629-30. No abstract available.

12.

New potential biomarkers for disease activity and fibrosis in systemic sclerosis.

Vadasz Z, Rimar D.

Isr Med Assoc J. 2014 Oct;16(10):629-30. No abstract available.

13.

The role of microRNAs in autoimmune diseases with skin involvement.

Deng X, Su Y, Wu H, Wu R, Zhang P, Dai Y, Chan TM, Zhao M, Lu Q.

Scand J Immunol. 2015 Mar;81(3):153-65. doi: 10.1111/sji.12261. Review.

PMID:
25430682
14.

Oxidative damage and antioxidative therapy in systemic sclerosis.

Grygiel-Górniak B, Puszczewicz M.

Mediators Inflamm. 2014;2014:389582. doi: 10.1155/2014/389582. Epub 2014 Sep 8.

15.

Update on scleroderma-associated interstitial lung disease.

Fan MH, Feghali-Bostwick CA, Silver RM.

Curr Opin Rheumatol. 2014 Nov;26(6):630-6. doi: 10.1097/BOR.0000000000000111. Review.

PMID:
25191993
16.

miRNAs in PAH: biomarker, therapeutic target or both?

Meloche J, Pflieger A, Vaillancourt M, Graydon C, Provencher S, Bonnet S.

Drug Discov Today. 2014 Aug;19(8):1264-9. doi: 10.1016/j.drudis.2014.05.015. Epub 2014 Jun 2. Review.

PMID:
24881781
17.

Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review.

Bălănescu P, Lădaru A, Bălănescu E, Băicuş C, Dan GA.

Biomarkers. 2014 Aug;19(5):345-55. doi: 10.3109/1354750X.2014.920046. Epub 2014 May 16. Review.

PMID:
24831309
18.

Personalized medicine in systemic sclerosis: facts and promises.

Dobrota R, Mihai C, Distler O.

Curr Rheumatol Rep. 2014 Jun;16(6):425. doi: 10.1007/s11926-014-0425-8. Review.

PMID:
24752884
19.

Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.

Altorok N, Almeshal N, Wang Y, Kahaleh B.

Rheumatology (Oxford). 2014 Apr 16. [Epub ahead of print]

PMID:
24740406
20.

MicroRNAs in IgA nephropathy.

Szeto CC, Li PK.

Nat Rev Nephrol. 2014 May;10(5):249-56. doi: 10.1038/nrneph.2014.50. Epub 2014 Apr 8. Review.

PMID:
24709842
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk